Cercar

01/06/2022 Connectomic-genetic signatures in the cerebral small vessel disease
Gutiérrez-Zúñiga R., Diez I., Bueichekú E., Kim C.-M., Orwig W., Montal V., Fuentes B., Díez-Tejedor E., Fernández M.G., Sepulcre J.. Connectomic-genetic signatures in the cerebral small vessel disease. NEUROBIOLOGY OF DISEASE. 2022; 167DOI:10.1016/j.nbd.2022.105671. PMID:35231560. IF:6.100(Q1/2D).
01/06/2022 DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients
Moreau, M, Carmona-Iragui, M, Altuna, M, Dalzon, L, Barroeta, I, Vilaire, M, Durand, S, Fortea, J, Rebillat, AS, Janel, N. DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients. Biomedicines. 2022; 10(6)DOI:10.3390/biomedicines10061380. PMID:35740400. IF:4.700(Q1/3D).
01/02/2022 Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders
Ramírez S., Haddad-Tóvolli R., Radosevic M., Toledo M., Pané A., Alcolea D., Ribas V., Milà-Guasch M., Pozo M., Obri A., Eyre E., Gómez-Valadés A.G., Chivite I., Van Eeckhout T., Zalachoras I., Altirriba J., Bauder C., Imbernón M., Garrabou G., Garcia-Ruiz C., Nogueiras R., Soto D., Gasull X., Sandi C., Brüning J.C., Fortea J., Jiménez A., Fernández-Checa J.C., Claret M.. Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders. Cell Metabolism. 2022; 34(2)DOI:10.1016/j.cmet.2021.12.023. PMID:35108514. IF:29.000(Q1/1D).
01/01/2022 Neurofilaments contribution in clinic: state of the art
Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments contribution in clinic: state of the art. Frontiers in Aging Neuroscience. 2022; 14DOI:10.3389/fnagi.2022.1034684. PMID:36389064. IF:4.800(Q2/3D).
01/02/2025 Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study
Guillén, N, Contador, J, Buongiorno, M, Alvarez, I, Culell, N, Alcolea, D, Lleó, A, Fortea, J, Piñol-Ripoll, G, Carnes-Vendrell, A, Ispierto, ML, Vilas, D, Puig-Pijoan, A, Fernández-Lebrero, A, Balasa, M, Sánchez-Valle, R, Lladó, A. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(1)DOI:10.1007/s00406-023-01701-y. PMID:37898567. IF:3.700(Q1/3D).
01/02/2025 Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis
Dols-Icardo, O, Carbayo, A, Jericó, I, Blasco-Martínez, O, Alvarez-Sánchez, E, Pérez, MAL, Bernal, S, Rodríguez-Santiago, B, Cusco, I, Turon-Sans, J, Cabezas-Torres, M, Caballero-Avila, M, Vesperinas, A, Llansó, L, Pagola-Lorz, I, Torné, L, Valle-Tamayo, N, Muñoz, L, Rubio-Guerra, S, Illán-Gala, I, Cortés-Vicente, E, Gelpi, E, Rojas-García, R. Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025; 96(2)DOI:10.1136/jnnp-2024-333834. PMID:38960585. IF:7.500(Q1/1D).
23/09/2024 Alzheimer Dementia Among Individuals With Down Syndrome
Rubenstein, E, Tewolde, S, Michals, A, Weuve, J, Fortea, J, Fox, MP, Jimenez, MP, Scott, A, Tripodis, Y, Skotko, BG. Alzheimer Dementia Among Individuals With Down Syndrome. JAMA Network Open. 2024; 7(9)DOI:10.1001/jamanetworkopen.2024.35018. PMID:39312235. IF:9.700(Q1/1D).
25/06/2024 Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019
Rubenstein, E, Tewolde, S, Skotko, BG, Michals, A, Fortea, J. Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS. 2024; 196(4)DOI:10.1002/ajmg.c.32097. PMID:38925597. IF:4.400(Q1/2D).
25/06/2024 What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?
Lleó, A, Alcolea, D. What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?. NEUROLOGY. 2024; 102(12)DOI:10.1212/WNL.0000000000209505. PMID:38830183. IF:8.500(Q1/1D).
13/06/2024 Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Navarro-Pérez, MP, González-Quintanilla, V, Muñoz-Vendrell, A, Madrigal, E, Alpuente, A, Latorre, G, Molina, F, Monzón, MJ, Medrano, V, García-Azorín, D, González-Oria, C, Gago-Veiga, A, Velasco, F, Beltrán, I, Morollón, N, Viguera, J, Casas-Limón, J, Rodriguez-Vico, J, Cuadrado, E, Irimia, P, Iglesias, F, Guerrero-Peral, áL, Belvís, R, Pozo-Rosich, P, Pascual, J, Santos-Lasaosa, S. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study. Frontiers in Neurology. 2024; 15DOI:10.3389/fneur.2024.1417831. PMID:38938776. IF:2.800(Q2/5D).
05/06/2024 Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum
Carbayo, A, Borrego-Écija, S, Turon-Sans, J, Cortés-Vicente, E, Molina-Porcel, L, Gascón-Bayarri, J, Rubio, MA, Povedano, M, Gámez, J, Sotoca, J, Juntas-Morales, R, Almendrote, M, Marquié, M, Sánchez-Valle, R, Illán-Gala, I, Dols-Icardo, O, Rubio-Guerra, S, Bernal, S, Caballero-Avila, M, Vesperinas, A, Gelpi, E, Rojas-García, R. Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum. BRAIN. 2024; 147(7)DOI:10.1093/brain/awae011. PMID:38227807. IF:11.700(Q1/1D).
17/05/2024 The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people
Jacobs, T, Jacobson, SR, Fortea, J, Berger, JS, Vedvyas, A, Marsh, K, He, TS, Gutierrez-Jimenez, E, Fillmore, NR, Gonzalez, M, Figueredo, L, Gaggi, NL, Plaska, CR, Pomara, N, Blessing, E, Betensky, R, Rusinek, H, Zetterberg, H, Blennow, K, Glodzik, L, Wisniweski, TM, de Leon, MJ, Osorio, RS, Ramos-Cejudo, J. The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people. Immunity & Ageing. 2024; 21(1)DOI:10.1186/s12979-024-00435-2. PMID:38760856. IF:5.600(Q1/1D).
11/05/2024 Addressing challenges in health care and research for people with Down syndrome
Fortea, J, McGlinchey, E, Espinosa, JM, Rafii, MS. Addressing challenges in health care and research for people with Down syndrome. LANCET. 2024; 403(10439)DOI:10.1016/S0140-6736(24)00478-1. PMID:38521088. IF:88.500(Q1/1D).
23/04/2024 On the road to biological blood diagnosis of Alzheimer's disease?
Delaby, C, Lehmann, S. On the road to biological blood diagnosis of Alzheimer's disease?. M S-MEDECINE SCIENCES. 2024; 40(4)DOI:10.1051/medsci/2024037. PMID:38651960. IF:0.400(Q4/10D).
01/04/2024 CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine
García-Azorín, D, Martínez-Badillo, C, Muñiz, JC, Gago-Veiga, AB, Sánchez, NM, González-Quintanilla, V, Porta-Etessam, J, Sierra-Mencia, A, Gonzalez-Garcia, N, González-Osorio, Y, Polanco-Fernandez, M, Recio-García, A, Nieto, RB, Guerrero-Peral, AL. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine. CEPHALALGIA. 2024; 44(4)DOI:10.1177/03331024241248833. PMID:38663908. IF:4.600(Q1/2D).
28/03/2024 A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors
Swift, IJ, Rademakers, R, Finch, N, Baker, M, Ghidoni, R, Benussi, L, Binetti, G, Rossi, G, Synofzik, M, Wilke, C, Mengel, D, Graff, C, Takada, LT, Sanchez-Valle, R, Antonell, A, Galimberti, D, Fenoglio, C, Serpente, M, Arcaro, M, Schreiber, S, Vielhaber, S, Arndt, P, Santana, I, Almeida, MR, Moreno, F, Barandiaran, M, Gabilondo, A, Stubert, J, Gomez-Tortosa, E, Agueero, P, Sainz, MJ, Gohda, T, Murakoshi, M, Kamei, N, Kittel-Schneider, S, Reif, A, Weigl, J, Jian, JL, Liu, CJ, Serrero, G, Greither, T, Theil, G, Lohmann, E, Gazzina, S, Bagnoli, S, Coppola, G, Bruni, A, Quante, M, Kiess, W, Hiemisch, A, Jurkutat, A, Block, MS, Carlson, AM, Bråthen, G, Sando, SB, Grontvedt, GR, Lauridsen, C, Heslegrave, A, Heller, C, Abel, E, Gómez-Núñez, A, Puey, R, Arighi, A, Rotondo, E, Jiskoot, LC, Meeter, LHH, Duraes, J, Lima, M, Tábuas-Pereira, M, Lemos, J, Boeve, B, Petersen, RC, Dickson, DW, Graff-Radford, NR, Leber, I, Sellami, L, Lamari, F, Clot, F, Borroni, B, Cantoni, V, Rivolta, J, Lleó, A, Fortea, J, Alcolea, D, Illán-Gala, I, Andres-Cerezo, L, Van Damme, P, Clarimon, J, Steinacker, P, Feneberg, E, Otto, M, van der Ende, EL, van Swieten, JC, Seelaar, H, Zetterberg, H, Sogorb-Esteve, A, Rohrer, JD. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors. Alzheimers Research & Therapy. 2024; 16(1)DOI:10.1186/s13195-024-01420-z. PMID:38539243. IF:7.600(Q1/1D).
08/03/2024 Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder
Pardo, J, Montal, V, Campabadal, A, Oltra, J, Uribe, C, Roura, I, Bargalló, N, Martí, MJ, Compta, Y, Iranzo, A, Fortea, J, Junqué, C, Segura, B. Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder. MOVEMENT DISORDERS. 2024; 39(5)DOI:10.1002/mds.29761. PMID:38456361. IF:7.600(Q1/1D).
01/03/2024 Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
Ashton N.J., Brum W.S., Di Molfetta G., Benedet A.L., Arslan B., Jonaitis E., Langhough R.E., Cody K., Wilson R., Carlsson C.M., Vanmechelen E., Montoliu-Gaya L., Lantero-Rodriguez J., Rahmouni N., Tissot C., Stevenson J., Servaes S., Therriault J., Pascoal T., Lleó A., Alcolea D., Fortea J., Rosa-Neto P., Johnson S., Jeromin A., Blennow K., Zetterberg H.. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurology. 2024; 81(3)DOI:10.1001/jamaneurol.2023.5319. PMID:38252443. IF:21.300(Q1/1D).
01/02/2024 Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum
Lorca-Puls DL, Gajardo-Vidal A, Mandelli ML, Illán-Gala I, Ezzes Z, Wauters LD, Battistella G, Bogley R, Ratnasiri B, Licata AE, Battista P, García AM, Tee BL, Lukic S, Boxer AL, Rosen HJ, Seeley WW, Grinberg LT, Spina S, Miller BL, Miller ZA, Henry ML, Dronkers NF, Gorno-Tempini ML. Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum. BRAIN. 2024; 147(2)DOI:10.1093/brain/awad327. PMID:37769652. IF:11.700(Q1/1D).
01/02/2024 Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease
Bejanin, A, Villain, N. Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease. LANCET NEUROLOGY. 2024; 23(2)DOI:10.1016/S1474-4422(23)00501-X. PMID:38267172. IF:45.500(Q1/1D).
25/01/2024 RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
del Rincón, CR, Gonzalez-Martinez, A, Quintas, S, García-Azorín, D, Lázaro, IF, Guerrero-Peral, AL, Osorio, YG, Santos-Lasaosa, S, Oria, CG, Rodríguez, NS, Díez, FI, Iñiguez, AE, Luque, SG, Huerta-Villanueva, M, Díaz, SC, Muñoz-Vendrell, A, Ros, AL, Sánchez-Soblechero, A, Juanes, FV, Kortazar-Zubizarreta, I, Echeverria, A, Rodríguez-Vico, J, Sánchez, AJ, Garcia, AG, Sánchez-Mateos, NM, Belvis, R, Pérez, MPN, García-Monco, JC, Escudero, MRA, Montes, N, Gago-Veiga, AB. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(4)DOI:10.1111/ene.16203. PMID:38270379. IF:3.900(Q1/3D).
16/01/2024 New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants
Mínguez-Olaondo, A, López-Bravo, A, Quintas, S, Nieves-Castellanos, C, Layos-Romero, A, Belvís, R, Irimia, P, Díaz-Insa, S. New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants. REVISTA DE NEUROLOGIA. 2024; 78(2)DOI:10.33588/rn.7802.2023176. PMID:38223948. IF:0.800(Q4/9D).
19/12/2023 Medical help-seeking intentions among patients with early Alzheimer's disease
Villarejo-Galende, A, García-Arcelay, E, Piñol-Ripoll, G, del Olmo-Rodríguez, A, Viñuela, F, Boada, M, Franco-Macías, E, de la Peña, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodríguez-Rodríguez, E, Vieira-Campos, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Lleó, A, Maurino, J. Medical help-seeking intentions among patients with early Alzheimer's disease. Frontiers in Psychiatry. 2023; 14DOI:10.3389/fpsyt.2023.1290002. PMID:38173708. IF:3.200(Q2/4D).
15/12/2023 Empathy as a crucial skill in disrupting disparities in global brain health
Fitri, FI, Lage, C, Mollayeva, T, Santamaria-Garcia, H, Chan, MLS, Cominetti, MR, Daria, T, Fallon, G, Gately, D, Gichu, M, Gimenez, S, Zuniga, RG, Hadad, R, Hill-Jarrett, T, O'Kelly, M, Martinez, L, Modjaji, P, Ngcobo, N, Nowak, R, Ogbuagu, C, Roche, M, Aguzzoli, CS, Shin, SY, Smith, E, Yoseph, SA, Zewde, Y, Ayhan, Y. Empathy as a crucial skill in disrupting disparities in global brain health. Frontiers in Neurology. 2023; 14DOI:10.3389/fneur.2023.1189143. PMID:38162446. IF:2.700(Q2/4D).
12/12/2023 Down Syndrome in a New Era for Alzheimer Disease
Rafii, MS, Fortea, J. Down Syndrome in a New Era for Alzheimer Disease. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2023; 330(22)DOI:10.1001/jama.2023.22924. PMID:37991807. IF:63.500(Q1/1D).
05/12/2023 Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease
Acha, B, Corroza, J, de Gordoa, JSR, Cabello, C, Robles, M, Mendez-López, I, Macías, M, Zueco, S, Roldan, M, Urdánoz-Casado, A, Jericó, I, Erro, ME, Alcolea, D, Lleo, A, Blanco-Luquin, I, Mendioroz, M. Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease. NEUROLOGY. 2023; 101(23)DOI:10.1212/WNL.0000000000207865. PMID:37827850. IF:8.400(Q1/1D).
01/12/2023 Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia
Hirschberg, Y, Valle-Tamayo, N, Dols-Icardo, O, Engelborghs, S, Buelens, B, Vandenbroucke, RE, Vermeiren, Y, Boonen, K, Mertens, I. Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 2023; 12(12)DOI:10.1002/jev2.12383. PMID:38082559. IF:15.500(Q1/1D).
03/08/2023 Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact
Olazarán J., Carnero-Pardo C., Fortea J., Sánchez-Juan P., García-Ribas G., Vinuela, F, Martínez-Lage P., Boada M.. Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01271-0. PMID:37537656. IF:8.000(Q1/1D).
01/08/2023 Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid
Gagliardi, G, Rodriguez-Vieitez, E, Montal, V, Sepulcre, J, Diez, I, Lois, C, Hanseeuw, B, Schultz, AP, Properzi, MJ, Papp, KV, Marshall, GA, Fortea, J, Johnson, KA, Sperling, RA, Vannini, P. Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. Communications Medicine. 2023; 3(1)DOI:10.1038/s43856-023-00324-7. PMID:37528163. IF:(Q/D).
26/07/2023 Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study
Hok-A-Hin, YS, Bolsewig, K, Ruiters, DN, Lleo, A, Alcolea, D, Lemstra, AW, van der Flier, WM, Teunissen, CE, del Campo, M. Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2023; 15(3)DOI:10.1002/dad2.12456. PMID:37502019. IF:(Q/D).
25/07/2023 Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist
Alcolea, D, Beeri, MS, Rojas, JC, Gardner, RC, Lleo, A. Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist. NEUROLOGY. 2023; 101(4)DOI:10.1212/WNL.0000000000207193. PMID:36878698. IF:8.400(Q1/1D).
31/05/2023 Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study
Aranha M.R., Coutinho A.M., Carneiro, CD, Pastorello B.F., Studart-Neto A., Guariglia C.C., Tsunemi M.H., Moreira, ELS, Ianof J.N., Anghinah R., Nitrini R., Cerri G.G., Fortea J., Buchpiguel C.A., Leite C.C.. Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study. ARQUIVOS DE NEURO-PSIQUIATRIA. 2023; 81(05)DOI:10.1055/s-0043-1768666. PMID:37257463. IF:1.000(Q4/8D).
25/05/2023 Burnout among neurologists caring for patients with cognitive disorders in Spain
Fortea, J, Garcia-Arcelay, E, Garcia-Ribas, G, Canal, N, Maurino, J. Burnout among neurologists caring for patients with cognitive disorders in Spain. PLoS One. 2023; 18(5)DOI:10.1371/journal.pone.0286129. PMID:37228146. IF:2.900(Q1/3D).
05/05/2023 Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia
Gonzalez, MC, Tovar-Rios, DA, Alves, G, Dalen, I, Williams-Gray, CH, Camacho, M, Forsgren, L, Backstrom, D, Lawson, RA, Macleod, AD, Counsell, CE, Paquet, C, DeLena, C, D'Antonio, F, Pilotto, A, Padovani, A, Blanc, F, Falup-Pecurariu, C, Lewis, SJG, Rejdak, K, Papuc, E, Hort, J, Nedelska, Z, O'Brien, J, Bonanni, L, Marquie, M, Boada, M, Pytel, V, Abdelnour, C, Alcolea, D, Beyer, K, Tysnes, OB, Aarsland, D, Maple-Grodem, J. Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia. Movement Disorders Clinical Practice. 2023; 10(6)DOI:10.1002/mdc3.13752. PMID:37332651. IF:2.600(Q2/5D).
24/04/2023 Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's disease
Mansilla, A, Canyelles, M, Ferrer, R, Arranz, J, Rodriguez-Baz, I, Zhu, N, Rubio-Guerra, S, El Bounasri, S, Sanchez, O, Torres, S, Fortea, J, Lleo, A, Alcolea, D, Tondo, M. Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's disease. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 61(9)DOI:10.1515/cclm-2023-0245. PMID:37083158. IF:3.800(Q1/2D).
01/04/2023 Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study
Montoliu-Gaya, L, Alcolea, D, Ashton, NJ, Pegueroles, J, Levin, J, Bosch, B, Lantero-Rodriguez, J, Carmona-Iragui, M, Wagemann, O, Balasa, M, Kac, PR, Barroeta, I, Llado, A, Brum, WS, Videla, L, Gonzalez-Ortiz, F, Benejam, B, Martinez, JJA, Karikari, TK, Nubling, G, Bejanin, A, Benedet, AL, Blesa, R, Lleo, A, Blennow, K, Sanchez-Valle, R, Zetterberg, H, Fortea, J. Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study. EBioMedicine. 2023; 90DOI:10.1016/j.ebiom.2023.104547. PMID:37002988. IF:9.700(Q1/1D).
13/03/2023 Purpose in life promotes resilience to age-related brain burden in middle-aged adults
Abellaneda-Perez, K, Cattaneo, G, Cabello-Toscano, M, Solana-Sanchez, J, Mulet-Pons, L, Vaque-Alcazar, L, Perellon-Alfonso, R, Sole-Padulles, C, Bargallo, N, Tormos, JM, Pascual-Leone, A, Bartres-Faz, D. Purpose in life promotes resilience to age-related brain burden in middle-aged adults. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01198-6. PMID:36915148. IF:8.000(Q1/1D).
25/01/2023 Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis
Álvarez-Velasco R., Dols-Icardo O., El Bounasri S., López-Vilaró L., Trujillo J.C., Reyes-Leiva D., Suárez-Calvet X., Cortés-Vicente E., Illa I., Gallardo E.. Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2)DOI:10.1212/NXI.0000000000200085. PMID:36697230. IF:8.300(Q1/1D).
01/01/2023 Caregiver knowledge of obstructive sleep apnoea in Down syndrome
Giménez S., Tapia I.E., Fortea J., Levedowski D., Osorio R., Hendrix J., Hillerstrom H.. Caregiver knowledge of obstructive sleep apnoea in Down syndrome. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH. 2023; 67(1)DOI:10.1111/jir.12990. PMID:36416001. IF:2.100(Q1/2D).
01/01/2023 Lessons from Down syndrome and autosomal dominant Alzheimer's disease
Fortea J., Quiroz Y.T., Ryan N.S.. Lessons from Down syndrome and autosomal dominant Alzheimer's disease. LANCET NEUROLOGY. 2023; 22(1)DOI:10.1016/S1474-4422(22)00437-9. PMID:36517171. IF:46.600(Q1/1D).